ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.94284
-0.17%
Brent Oil
83.855
0.27%
Bitcoin
59,013.14
-0.18%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. OptiNose Inc (OPTN)

  7. OptiNose Inc (OPTN) Noticias

OPTN OptiNose Inc

0.8779
0.0003 (0.03%)
Pre Mercado
Última actualización: 04:35:43
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
OptiNose Inc OPTN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0003 0.03% 0.8779 04:35:43
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.8776
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
25/4/202406:00GLOBEOptinose Provides Corporate Update on XHANCE Launch and..
04/4/202415:01GLOBEOptinose to Present at the Needham Virtual Healthcare..
15/3/202414:34GLOBEXHANCE Approved by FDA as First and Only Medication..
08/3/202415:10EDGAR2Form 8-K - Current report
07/3/202415:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202406:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202406:00GLOBEOptinose Reports Fourth Quarter and Full Year 2023 Financial..
07/3/202406:00EDGAR2Form 8-K - Current report
29/2/202415:40GLOBEOptinose Announces Reporting Date for Fourth Quarter 2023..
29/2/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202406:08EDGAR2Form 8-K - Current report
22/2/202415:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202416:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202413:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202411:00GLOBEOptinose Announces the Publication of ReOpen Phase 3..
21/12/202315:11EDGAR2Form 8-K - Current report
20/12/202311:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202311:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202307:48DJNOptinose Shares Slide Premarket as FDA Extends Xhance Review
06/12/202306:02EDGAR2Form 8-K - Current report
06/12/202306:00GLOBEOptinose Announces 3-Month Extension of FDA Review Period..
22/11/202308:00GLOBEOptinose to Present at the 35th Annual Piper Sandler..
09/11/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:02EDGAR2Form 8-K - Current report
09/11/202306:00GLOBEOptinose Reports Third Quarter 2023 Financial Results and..
27/10/202307:00GLOBEOptinose Announces Reporting Date for Third Quarter 2023..
22/9/202308:01GLOBEOptinose to Present at the 2023 Cantor Global Healthcare..
19/9/202318:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202318:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/8/202315:05EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202306:02EDGAR2Form 8-K - Current report
10/8/202306:00GLOBEOptinose Reports Second Quarter 2023 Financial Results and..
27/7/202306:27EDGAR2Form 8-K - Current report
27/7/202306:00GLOBEOptinose Announces Preliminary Second Quarter 2023 XHANCE..
16/6/202315:08GLOBEOptinose Announces Inducement Grant Under Nasdaq Listing..
02/6/202312:00GLOBEOptinose to Present at the Jefferies Healthcare Conference
11/5/202306:00GLOBEOptinose Reports First Quarter 2023 Financial Results and..
04/5/202306:00GLOBEOptinose Announces FDA Acceptance of Supplemental New Drug..

Su Consulta Reciente

NASDAQ
OPTN
OptiNose
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados